• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/7

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

7 Cards in this Set

  • Front
  • Back
) Small/medium blasts; scant
cytoplasm; indistinct nuleoli
CD10, CD19, TdT with aberrant
expression of CD13 and CD33
Worst prognosis of all ALL
w/t(9;22)(q34;q11.2)
d Small/medium blasts; scant
cytoplasm; indistinct nuleoli.
May be able to recognize
monoblastic component in
blood or bone marrow
CD19, CD15 positive; CD10,
CD14 negative
Poor, especially in patients <6mo.
w/t(v11q23);MLL rearranged
Small/medium blasts; scant
cytoplasm; indistinct nuleoli
CD10, CD19 Positive; Most
CD34 positive; Lack CD20;
Often express CD13
w/t(12;21
Small/medium blasts; scant
cytoplasm; indistinct nuleoli
CD10, CD19 Positive; Often
CD34+, CD45dim or absent
Numerical increases in
chromosomes, usually without
structural abnormalities. Usually Ch
21, X, 14 and 4 copy number
changes
w/hyperdiploidy
Small/medium blasts; scant
cytoplasm; indistinct nuleoli
Loss of one or more chromosome.
Structural abnormalities may be
seen in other chromosomes.
Hypodiploid may be detected by
flow cytometry.
Poor prognosis, worse with greater loss of material
CD10, CD19
w/hypodiploidy
) Small/medium blasts; scant
cytoplasm; indistinct nuleoli.
Associated with an increase in
circulating eosinophils. This is
a reactive change and not part
of the neoplastic process
CD10, CD19 --Uncertain

) Functional rearrangement
of the IL3 gene on Chromosome 5
with IGH gene on 14. Constitutive
expression of IL3
w/t(5;14)
Medium uniform blasts with
high proliferative rate. Does
not occur in peripheral blood,
even with bone marrow
involvment --- TdT negative
CD10, CD19, CD20, CD22;
Aggressive but curable, especially early in disease.
w/t(1;19)